D. Foster

发表

Endotoxaemia in Critical Illness: Rapid Detection and Clinical Relevance

J. Marshall, A. Romaschin, D. Foster, 1999 .

Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial

S. Bagshaw, D. Foster, P. Walker, 2018, Intensive Care Medicine.

Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial

D. Foster, D. Klein, L. Weisberg, 2020, Critical care explorations.

Measures, markers, and mediators: Toward a staging system for clinical sepsis. A Report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25–26, 2000

D. Cook, J. Marshall, G. Rubenfeld, 2003, Critical care medicine.

Endotoxin Removal: Bringing the Mission to North America

D. Foster, P. Walker, G. Guadagni, 2014, Blood Purification.

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

R. F. Johnston, Robert W. Taylor, Steven C. Johnson, 1994 .

Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study.

D. Cook, J. Marshall, S. Opal, 2004, The Journal of infectious diseases.

Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence

J. Marshall, A. Romaschin, D. Foster, 2002, Critical care.

Endotoxemia is common following abdominal organ transplantation and is associated with reperfusion and rejection

J. Kellum, D. Foster, K. Abu-Elmagd, 2009 .

Let the Cells Speak: Neutrophils as Biologic Markers of the Inflammatory Response

J. Marshall, A. Romaschin, D. Foster, 1998, Sepsis.

Use of a screen log to audit patient recruitment into multiple randomized trials in the intensive care unit

D. Cook, J. Granton, M. Steinberg, 2000, Critical care medicine.

Evidence-Based Clinical Practice Guideline for the Prevention of Ventilator-Associated Pneumonia

D. Cook, S. Keenan, D. Heyland, 2004, Annals of Internal Medicine.

Can sepsis be better defined? Contribution of a novel assay for endotoxin

D. Foster, J. Keffer, A. Derzko, 2004 .

Endotoxin removal: how far from the evidence? From EUPHAS to EUPHRATES.

R. Dellinger, R. Dellinger, D. Foster, 2010, Contributions to nephrology.

Endotoxemia in Critically Ill Patients with COVID-19

D. Foster, S. Mallipattu, Sobia Khan, 2021, Blood Purification.

Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial

J. Marshall, M. Antonelli, S. Bagshaw, 2018, JAMA.

The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial

R. Dellinger, C. Schorr, D. Foster, 2014, Trials.

DAILY VARIATION IN ENDOTOXIN LEVELS IS ASSOCIATED WITH INCREASED ORGAN FAILURE IN CRITICALLY ILL PATIENTS

J. Marshall, A. Seely, A. Romaschin, 2007, Shock.

Influence of perceived functional and employment status on cardiopulmonary resuscitation directives.

G. Guyatt, D. Cook, M. Levy, 2003, Journal of critical care.

A novel method for the rapid detection of human endotoxaemia

A. Romaschin, D. Foster, A. Derzko, 2004 .

Endotoxemic Sepsis: Clinical Features and Therapy

J. Kellum, D. Foster, H. Shoji, 2022, Journal of Translational Critical Care Medicine.

Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome.

J. Marshall, M. Steinberg, D. Foster, 1997, Archives of surgery.

A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence.

J. Marshall, A. Romaschin, D. Foster, 1998, Journal of immunological methods.

Targeted therapy using polymyxin B hemadsorption in patients with sepsis: a post-hoc analysis of the JSEPTIC-DIC study and the EUPHRATES trial

J. Kellum, T. Goto, S. Kushimoto, 2023, Critical Care.

Endotoxemic Shock: A Molecular Phenotype in Sepsis

J. Kellum, D. Foster, P. Walker, 2022, Nephron.